Despite the detection of TP53 gene mutations in approximately 50% of tumor samples, the presence of these mutations reveals more about the complexity of tumorigenesis than a singular causal relationship (Kennedy and Lowe, 2022; Levine, 2020; Levine, 2021). Here, TP53 is linked to neoplasm.